David Levy
About David Levy
David Levy is a Professor at NYU Langone Health and Chief Scientific Officer at Lab11 Therapeutics Inc. He directs the Molecular Oncology and Tumor Immunology Training Program at NYU School of Medicine.
Current Role at Lab11 Therapeutics Inc.
David Levy currently serves as the Chief Scientific Officer at Lab11 Therapeutics Inc. This role is based in New York, New York, United States, and began in 2021. His responsibilities likely include overseeing the scientific operations and strategic direction of the company's research and development activities.
Director at NYU School of Medicine
David Levy has been the Director of the Molecular Oncology and Tumor Immunology Training Program at NYU School of Medicine since 2010. This role involves leadership in educating and training the next generation of scientists in the fields of molecular oncology and tumor immunology.
Former Associate Dean at NYU School of Medicine
David Levy held the position of Associate Dean at NYU School of Medicine from 2009 to 2018. During his nine-year tenure, he contributed to the administration and development of the school's academic programs and initiatives.
Academic Career
David Levy has had a long-standing career as a Professor at NYU Langone Health since 1988. He has also been involved in the Departments of Pathology and Microbiology at the NYU School of Medicine. His academic roles highlight his deep commitment to teaching and research in pathology, microbiology, and related fields.
Postdoctoral Fellow at Rockefeller University
From 1985 to 1988, David Levy worked as a Postdoctoral Fellow at Rockefeller University. This period was focused on advanced training and research in molecular cell biology, preparing him for his future academic and scientific endeavors.
Graduate Studies at Caltech
David Levy completed his Ph.D. in Molecular Biology at Caltech, where he was a graduate student from 1978 to 1985. His years at Caltech were foundational in shaping his expertise and career in molecular biology.